Essential Roles of Gangliosides in the Formation and Maintenance of Membrane Microdomains in Brain Tissues

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2012 Apr 11

PMID 22488331

Citations 35

Authors

Yuhsuke Ohmi

Yuki Ohkawa

Yoshio Yamauchi

Orie Tajima

Keiko Furukawa

Koichi Furukawa

Affiliations

Soon will be listed here.

Abstract

Gangliosides are considered to be involved in the maintenance and repair of nervous tissues. Recently, novel roles of gangliosides in the regulation of complement system were reported. Here we summarized roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues by comparing complement activation, inflammatory reaction and disruption of glycolipid-enriched microdomain (GEM)/rafts among several mutant mice of ganglioside synthases. Depending on the defects in ganglioside compositions, corresponding up-regulation of complement-related genes, proliferation of astrocytes and infiltration of microglia were found with gradual severity. Immunoblotting of fractions separated by sucrose density gradient ultracentrifugation revealed that DAF and NCAM having GPI-anchors tended to disappear from the raft fraction with intensities of DKO > GM2/GD2 synthase KO > GD3 synthase KO > WT. The lipid raft markers tended to disperse from the raft fractions with similar intensities. Phospholipids and cholesterol also tended to decrease in GEM/rafts in GM2/GD2 synthase KO and DKO, although total amounts were almost equivalent. All these results indicate that GEM/rafts architecture is destroyed by ganglioside deficiency with gradual intensity depending on the degree of defects of their compositions. Implication of inflammation caused by deficiency of gangliosides in various neurodegenerative diseases was discussed.

Citing Articles

Strategies to manage the adverse effects of immunotherapy with dinutuximab beta in neuroblastoma: an Italian experience and literature review.

Amoroso L, Fagioli F, Tondo A, Conte M, Badino C, Di Cataldo A Support Care Cancer. 2025; 33(3):153.

PMID: 39907793 DOI: 10.1007/s00520-024-09135-5.

From mechanism to therapy: the journey of CD24 in cancer.

Zhao K, Wu C, Li X, Niu M, Wu D, Cui X Front Immunol. 2024; 15:1401528.

PMID: 38881902 PMC: 11176514. DOI: 10.3389/fimmu.2024.1401528.

GD3 ganglioside is a promising therapeutic target for glioma patients.

Hein V, Baeza-Kallee N, Bertucci A, Colin C, Tchoghandjian A, Figarella-Branger D Neurooncol Adv. 2024; 6(1):vdae038.

PMID: 38590763 PMC: 11000324. DOI: 10.1093/noajnl/vdae038.

GD2-targeting therapy: a comparative analysis of approaches and promising directions.

Philippova J, Shevchenko J, Sennikov S Front Immunol. 2024; 15:1371345.

PMID: 38558810 PMC: 10979305. DOI: 10.3389/fimmu.2024.1371345.

Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.

Sengul T, Can M, Ates N, Seyrantepe V PLoS One. 2023; 18(3):e0280650.

PMID: 36928510 PMC: 10019743. DOI: 10.1371/journal.pone.0280650.

References

Simons K, Gerl M . Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol. 2010; 11(10):688-99. DOI: 10.1038/nrm2977. View

Tajima O, Egashira N, Ohmi Y, Fukue Y, Mishima K, Iwasaki K . Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging. Behav Brain Res. 2008; 198(1):74-82. DOI: 10.1016/j.bbr.2008.10.024. View

Farkas I, Takahashi M, Fukuda A, Yamamoto N, Akatsu H, Baranyi L . Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J Immunol. 2003; 170(11):5764-71. DOI: 10.4049/jimmunol.170.11.5764. View

Sugiura Y, Tajima O, Mii S, Honda T, Furukawa K . Sensory nerve-dominant nerve degeneration and remodeling in the mutant mice lacking complex gangliosides. Neuroscience. 2005; 135(4):1167-78. DOI: 10.1016/j.neuroscience.2005.07.035. View

Ledeen R, Wu G . Sphingolipids of the nucleus and their role in nuclear signaling. Biochim Biophys Acta. 2006; 1761(5-6):588-98. DOI: 10.1016/j.bbalip.2006.04.010. View

Yasojima K, Schwab C, McGeer E, McGeer P . Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am J Pathol. 1999; 154(3):927-36. PMC: 1866427. DOI: 10.1016/S0002-9440(10)65340-0. View

Yamada K, Miwa T, Liu J, Nangaku M, Song W . Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol. 2004; 172(6):3869-75. DOI: 10.4049/jimmunol.172.6.3869. View

Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C . Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci U S A. 2005; 102(35):12459-64. PMC: 1194904. DOI: 10.1073/pnas.0500893102. View

Benard M, Gonzalez B, Schouft M, Falluel-Morel A, Vaudry D, Chan P . Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J Biol Chem. 2004; 279(42):43487-96. DOI: 10.1074/jbc.M404124200. View

10.

Rahpeymai Y, Hietala M, Wilhelmsson U, Fotheringham A, Davies I, Nilsson A . Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J. 2006; 25(6):1364-74. PMC: 1422160. DOI: 10.1038/sj.emboj.7601004. View

11.

Sheikh K, Sun J, Liu Y, Kawai H, Crawford T, Proia R . Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A. 1999; 96(13):7532-7. PMC: 22120. DOI: 10.1073/pnas.96.13.7532. View

12.

Tenner A . Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events. Neurobiol Aging. 2002; 22(6):849-61. DOI: 10.1016/s0197-4580(01)00301-3. View

13.

Rogers J, Cooper N, Webster S, Schultz J, McGeer P, Styren S . Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A. 1992; 89(21):10016-20. PMC: 50268. DOI: 10.1073/pnas.89.21.10016. View

14.

Pan B, Fromholt S, Hess E, Crawford T, Griffin J, Sheikh K . Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol. 2005; 195(1):208-17. PMC: 1852502. DOI: 10.1016/j.expneurol.2005.04.017. View

15.

Simons K, Ikonen E . Functional rafts in cell membranes. Nature. 1997; 387(6633):569-72. DOI: 10.1038/42408. View

16.

Hara-Yokoyama M . Gangliosides potentially inhibit extracellular nucleotide metabolism. Curr Med Chem. 2006; 13(19):2233-9. DOI: 10.2174/092986706777935177. View

17.

Takamiya K, Yamamoto A, Yamashiro S, Shin M, Okada M, Fukumoto S . Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A. 1996; 93(20):10662-7. PMC: 38211. DOI: 10.1073/pnas.93.20.10662. View

18.

Terai K, Walker D, McGeer E, McGeer P . Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 1997; 769(2):385-90. DOI: 10.1016/s0006-8993(97)00849-4. View

19.

Inoue M, Fujii Y, Furukawa K, Okada M, Okumura K, Hayakawa T . Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem. 2002; 277(33):29881-8. DOI: 10.1074/jbc.M201631200. View

20.

Lin F, Salant D, Meyerson H, Emancipator S, Morgan B, Medof M . Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis. J Immunol. 2004; 172(4):2636-42. DOI: 10.4049/jimmunol.172.4.2636. View